Study of Multiple Doses of Danicopan in Healthy Participants
Status:
Completed
Trial end date:
2017-01-11
Target enrollment:
Participant gender:
Summary
This was a multiple ascending dose, randomized, double-blind study assessing the safety,
tolerability, pharmacokinetics, and pharmacodynamics of danicopan in healthy participants.
Four different doses (75 milligrams [mg], 200 mg, 500 mg, 800 mg) and dose-matched placebo
were administered under fasted conditions.